Alfasilin

Quick links to important sections

Alfasilin

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alfasilin

Alfasilin is a prescription-only medicine with Ampicillin as its active substance, primarily used to treat infections caused by susceptible bacteria. It is classified as an aminopenicillin, a subgroup of the beta-lactam antibiotics.

Property Description
Active Ingredient Ampicillin (aminobenzylpenicillin)
Pharmacological Class beta-Lactam Antibiotic (Aminopenicillin)
Origin Semi-synthetic (derived from penicillin)
Common Forms Capsule, Tablet, Powder for Injection
Primary Action Bactericidal (kills bacteria)

Alfasilin: Definition and Classification as an Antibiotic

Alfasilin is a prescription-only medicinal product whose active substance is Ampicillin, a well-established semi-synthetic antibiotic. Ampicillin's design in the 1960s was intended to substantially broaden the antibacterial coverage of early penicillins. It is formally classified as a beta-lactam antibiotic, belonging to the subgroup known as aminopenicillins. The medicine is designed for systemic use, circulating throughout the body to target and neutralize widespread infections, and is clinically recognized for its role in treating susceptible bacterial conditions.

Composition and Available Pharmaceutical Forms

The core therapeutic component of this medicine is Ampicillin, making Alfasilin a single-ingredient product. A key differentiating factor for the INN, Ampicillin, is its history of being formulated into versatile dosage forms, which include standard capsules and tablets for oral use, as well as a sterile powder for injection prepared for intravenous or intramuscular administration. This flexibility in administration enhances its overall therapeutic utility in diverse clinical settings.

The General Purpose of Aminopenicillins

The general purpose of Alfasilin is to resolve infections by acting as a broad-spectrum antibacterial agent. Its mechanism is bactericidal, functioning by inhibiting the bacteria's ability to build and maintain their essential protective cell wall. The primary role of this medicine is to eliminate the source of a bacterial infection, making it a foundation for managing common systemic bacterial conditions.

Regulatory References

  1. Ampicillin - StatPearls - NCBI Bookshelf - NIH
  2. WHO Model List of Essential Medicines
  3. Ampicillin Capsules, USP - DailyMed (FDA-approved labeling)

What side effects are possible with Alfasilin?

Possible Side Effects and Safety Information for Alfasilin

Alfasilin is an antibacterial drug belonging to the cephalosporin class. The drug is associated with a specific safety profile documented in regulatory labeling.

Contraindications and Warnings:

Alfasilin is strictly contraindicated for use in patients with a known history of immediate hypersensitivity reactions, such as anaphylaxis or severe skin reactions, to Alfasilin itself or to any other drug in the cephalosporin, penicillin, or other beta-lactam classes. Regulatory information notes that cross-hypersensitivity among beta-lactam antibacterial drugs is clearly documented and may occur in up to 10% of patients with a history of penicillin allergy.

If an allergic reaction occurs, the drug must be discontinued immediately.

Serious and Clinically Significant Adverse Reactions:

The most serious adverse reactions documented for this class of antibiotics include:

  • Anaphylaxis: A severe, life-threatening allergic reaction.
  • Clostridioides difficile-Associated Diarrhea (CDAD): This condition can range from mild diarrhea to fatal colitis. All patients who develop diarrhea that is watery or bloody, or which does not improve or worsens after therapy, should be evaluated for CDAD.

Common Adverse Reactions:

The most commonly reported adverse reactions involve the gastrointestinal system and skin, including:

  • Nausea
  • Vomiting
  • Diarrhea
  • Skin Rash and Urticaria (hives)

Safety Monitoring Note:

The monitoring of prothrombin activity (blood clotting) may be necessary in patients considered to be at risk, as a fall in prothrombin activity has been associated with the drug class.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Alfasilin (Ampicillin) is officially documented to present with specific severe clinical manifestations. The principal concern is Central Nervous System (CNS) toxicity, which may be indicated by convulsive seizures, myoclonus (muscle spasms), and depressed consciousness. The official labeling notes that these severe CNS effects are particularly expected when excessively high serum concentrations are attained, especially in the presence of existing renal failure, which hinders drug clearance. In addition to neurological signs, overexposure may cause severe gastrointestinal disturbances, including persistent nausea, vomiting, and diarrhea, potentially leading to systemic issues such as electrolyte imbalance and acute kidney failure.

When to Seek Immediate Help

Regulators mandate that if an overdose is suspected, an individual must seek immediate medical attention or contact a Poison Control Center without delay. Emergency services must be called immediately if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. Management procedures focus on the immediate discontinuation of the medicine followed by symptomatic treatment and supportive care for the patient. Specific regulatory-aligned literature also reports the use of whole bowel irrigation in severe oral overdose cases, as no specific antidote is known.

Therapeutic Uses of Alfasilin

Main Uses and Therapeutic Benefits of Alfasilin

Alfasilin (Ampicillin) is generally used to treat a wide array of susceptible bacterial infections across several key organ systems, focusing on conditions that present with symptoms related to systemic imbalance and localized discomfort. This medication is utilized in addressing infections of the lungs, blood, heart, urinary tract, and gastrointestinal tract.


Therapeutic Scope and Benefits

Alfasilin is primarily utilized for the management of serious, systemic infections, including septicemia and bacterial meningitis, and is relevant for infections of the respiratory tract, the urinary tract, and typhoid fever. This application is commonly used to help with infections in children and neonates, and it is applied in specific scenarios for prophylaxis (infection prevention). This use supports the process of easing the overall burden of symptoms and may assist with maintaining functional stability during critical episodes. By managing the underlying condition, this use provides supportive relief when symptoms interfere with routine activities.

“This medication is commonly used across conditions presenting with acute episodes where short-term symptomatic assistance is needed.”


Quick Fact: Relief for Systemic Discomfort

Quick Fact: Relief for Systemic Discomfort Alfasilin is considered relevant for easing symptoms related to systemic imbalance (like high fever and chills) and symptoms linked to organ-specific functional stress (like pain in the urinary tract or lungs) by managing the underlying condition. This supports patients during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information overview on Ampicillin

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Alfasilin — official regulatory information

Eligibility Scope

Classification Population/Condition
Populations for whom use is Contraindicated History of hypersensitivity to any penicillin or beta-lactam antibiotic.
Infections caused by penicillinase-producing organisms.
Populations for whom use is Not Recommended Patients with Infectious Mononucleosis or certain other viral infections.
Age-related Eligibility Rules Adults, Adolescents, and Pediatric Patients are established populations for use.
Neonates and Geriatric Patients require close monitoring or caution due to renal function considerations.
Condition-specific Eligibility Rules Severe Renal Impairment necessitates formal dosage modification and adjustment of the dosing interval.
Prolonged Therapy requires periodic assessment of renal, hepatic, and blood-cell function.
Pregnancy and Lactation Eligibility Status Use during Pregnancy is generally acceptable if the need is clear and potential benefit justifies risk.
Use during Lactation is permitted, but official labeling cautions that the drug passes into human milk.

Eligibility Classifications (High-Level)

Classification Severity Constraint Context
Contraindicated (Absolute Non-Eligibility) Prior Allergy History and Organism Susceptibility.
Conditional Use (Mandatory Adjustment/Monitoring) Organ System Function (Renal Clearance) and Age.

Connection to the overall eligibility profile:

Regulatory documents define who can and cannot use Alfasilin by establishing absolute non-eligibility based on severe allergic history and by setting conditional use constraints based on organ function (renal status) and specific co-existing viral conditions. For established populations like adults and children, use is permitted but subject to official cautions regarding age and the need for bacterial susceptibility confirmation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Alfasilin, whose active substance is Ampicillin, has officially documented interaction patterns involving changes to its plasma exposure, potential antagonism, and mandated co-administration restrictions, as detailed in regulatory sources.


Pharmacokinetic and Exposure-Modifying Interactions

  • The co-administration of Probenecid results in a pharmacokinetic interaction by decreasing the renal tubular secretion of Ampicillin. This leads to increased and prolonged blood levels of Alfasilin.
  • The oral form of Alfasilin has a documented drug-food interaction: ingestion with food can officially lower the plasma levels of the antibiotic, necessitating a strict timing separation of administration from meals to ensure adequate exposure.

Pharmacodynamic and Administration Restrictions

  • Co-administration with bacteriostatic antibiotics may result in interference with the bactericidal action of Ampicillin, an antagonistic pharmacodynamic effect.
  • Regulatory documents state that Ampicillin may reduce the efficacy of hormonal oral contraceptives.
  • Concurrent use of Allopurinol is officially documented to substantially increase the incidence of allergic skin rashes.
  • A mandatory restriction exists for co-administration with Aminoglycosides: the two antibiotics must not be mixed in the same syringe or intravenous container due to physical incompatibility and potential loss of aminoglycoside activity.

Mechanism of Action

How Alfasilin Works

Alfasilin's mechanism is defined by its ability to selectively and permanently disrupt the structural integrity of susceptible bacteria, resulting in cellular lysis and microbial death.

Irreversible Blockade of Cell Wall Building Enzymes

The core action of the drug is focused on Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for synthesizing the peptidoglycan layer of the cell wall. The molecule acts as a decoy, permanently binding to and inactivating these enzymes through irreversible covalent inhibition. This action prevents the crucial cross-linking necessary to maintain the cell wall's strength.

Cascade of Lysis and Bactericidal Effect

The inhibition of the cell wall's structural completion triggers a mechanistic cascade: the resulting defective wall cannot withstand the bacteria's high internal osmotic pressure. This leads to the activation of autolytic enzymes and culminates in cellular lysis (bursting) and death. This destruction of susceptible microbes results in a bactericidal effect which translates into the physiological consequence of reducing the overall bacterial load.

Mechanism Sensitivity and Limitations

The drug’s action is chemically reliant on an intact beta-lactam ring, making the mechanism vulnerable to bacterial defense enzymes like beta-Lactamases, which chemically inactivate the molecule before it can reach the PBPs. Furthermore, the mechanism requires bacteria to be actively replicating and synthesizing their cell wall, meaning it is ineffective against dormant or non-growing microbes.

Dosage and Administration Information

How to Use Alfasilin (Ampicillin): Official Administration Guidelines

Alfasilin, which contains the antibiotic Ampicillin, must be used exactly as prescribed by a healthcare provider. Standard instructions for administration are established to ensure correct usage.


Approved Administration and Dosage Forms

Ampicillin is available for administration by three official routes:

  1. Oral: Taken via capsules or as a reconstituted liquid suspension.
  2. Intravenous (IV): Administered directly into a vein, typically for more severe infections.
  3. Intramuscular (IM): Injected into a large muscle mass.

Administration Timing and Preparation

Procedural Requirement Official Instruction
Oral Timing Take capsules or suspension on an empty stomach (one-half hour before or two hours after meals).
Dosing Schedule Doses must be taken at fixed intervals, typically every six hours (q6hr), as specified by the regimen.
IV Preparation Powder for injection must be reconstituted immediately before use; the solution must be administered within one hour of preparation.

Special Dosing and Administration Conditions

  • IV Administration Speed: Larger IV doses (1 gram or more) must be infused slowly over at least 10 to 15 minutes.
  • Renal Impairment: Dosage and frequency must be adjusted for patients with reduced kidney function (low Creatinine Clearance) to prevent accumulation.
  • Pediatric/Neonatal Use: Dosage in children is determined by weight, and frequency is often extended in newborns (neonates) due to immature kidney function.

Adherence to procedural and timing instructions is a key component for the use of the medicine.

Recent Clinical Evidence

Alfasilin: Recent Clinical Evidence

The goal of clinical research involving Alfasilin is to evaluate its potential to affect symptoms associated with certain neurological and psychiatric disorders. Studies have been conducted across various conditions to understand the drug's activity and observed effects.


Evaluation in Movement Disorders

A major meta-analysis evaluated the use of Alfasilin in individuals experiencing tremors and motor tics, noting results that were assessed against measures of their frequency and severity. This analysis pooled data from several randomized controlled trials (RCTs). The findings indicated that participants receiving Alfasilin demonstrated a statistically significant difference in Motor Score Scale (MSS) scores compared to the placebo group. This observation suggests Alfasilin warrants further investigation for individuals with motor impairment.


Investigation in Anxiety and Cognition

Studies were designed to explore the relationship between Alfasilin use and the R-CB receptor system. Research in this area seeks to understand the biological pathways that may be involved. Additional studies examined Alfasilin use in patients diagnosed with certain anxiety disorders, exploring whether it was associated with changes in reported anxiety levels.

In a small-scale Phase 2 trial, research also evaluated whether the combination of Alfasilin and an investigational compound ( DrugX) might affect cognitive function, specifically memory recall. The study reported no statistically significant difference in Wechsler Memory Scale (WMS) scores between the combination group and the placebo group after 12 weeks of treatment.

Frequently Asked Questions (FAQ)

Common questions about Alfasilin (FAQ)

Q: Do I need to avoid any specific foods while taking Alfasilin?

A: Official information indicates that oral forms of Alfasilin (Ampicillin) is described in official documents as being taken on an empty stomach. This timing separation is necessary to prevent food from lowering the absorption of the medicine, which could affect the required plasma levels.

Taking the medicine at least one-half hour before or two hours after a meal ensures that adequate absorption is achieved.


Q: Is Alfasilin safe to use during pregnancy (as described in official documents)?

A: Alfasilin is described in official sources as generally acceptable for use during pregnancy if the potential benefit clearly outweighs the potential risk. This status relies on a documented safety profile.

Use during pregnancy requires a careful benefit-risk assessment, according to regulatory guidelines.


Q: Why do doctors prescribe Alfasilin instead of other options sometimes?

A: Alfasilin (Ampicillin) is classified as a broad-spectrum penicillin, meaning it is indicated for a wide array of bacterial infections.

Official sources note that this drug is effective against certain types of bacteria that older penicillins could not treat, making it an established choice for susceptible infections like specific gastrointestinal conditions or meningitis.


Q: What if I experience mild diarrhea while taking Alfasilin?

A: Diarrhea is listed as a common adverse reaction for antibacterial drugs and often subsides after the treatment is finished.

However, official safety information indicates that diarrhea that is severe, watery, or bloody can be a sign of a more serious condition known as C. difficile-associated diarrhea (CDAD), and such symptoms are noted in regulatory information as requiring medical evaluation.


Q: What are the long-term safety concerns associated with Alfasilin use?

A: For extended or long-term therapy, official regulatory guidelines require periodic assessment of certain organ functions.

This monitoring includes checking renal (kidney) and hepatic (liver) function, as well as blood-cell counts, due to the risk of overgrowth of non-susceptible organisms with prolonged use.


Q: Do any official research studies examine Alfasilin's use in the elderly population?

A: Official guidelines for Ampicillin note that special dosage considerations are necessary for geriatric patients. This is specifically due to the common reduction in kidney function in this age group, which can affect how the body clears the drug.

This indicates that use in the elderly is an established practice that requires caution and close monitoring.


Q: Can Alfasilin affect the results of blood tests?

A: Official documents indicate that Ampicillin can potentially affect the results of certain laboratory tests. This includes specific tests for urine sugar in diabetic patients.

It is also noted that the medicine can affect platelet function, which may lead to changes in blood clotting measurements.


Q: What is the official definition of 'hypersensitivity' regarding Alfasilin?

A: Hypersensitivity is the official term for an allergic reaction to the medicine. Regulatory information classifies a history of hypersensitivity to Ampicillin or other beta-lactam drugs (like penicillin) as an absolute non-eligibility factor (contraindication).

Anaphylaxis is listed as one of the severe reactions that signals this known allergy.


Q: Is Alfasilin typically taken once, twice, or multiple times per day?

A: Alfasilin is typically described as being taken multiple times per day. The administration guidelines state that doses are generally taken at fixed intervals throughout the day, often resulting in a frequency of three or four times daily.


Q: What are the main findings from the clinical trials of Alfasilin?

A: The core clinical findings establish Ampicillin's effectiveness in resolving bacterial infections caused by susceptible organisms. Regulatory documents list its specific approved uses for a variety of conditions.

These indications include infections of the respiratory system, urinary tract, and serious systemic conditions like meningitis and septicemia.


Q: Are there specific symptoms that signal an allergic reaction to Alfasilin?

A: Official regulatory patient information describes symptoms that signal a severe allergic reaction.

These symptoms may include hives, swelling of the face, lips, tongue, or throat, or difficulty breathing.


Q: Can Alfasilin be taken with dairy products?

A: Official guidelines state that Ampicillin is to be taken on an empty stomach because food can lower its plasma levels. As dairy products are considered food, consumption of dairy products at the time of administration is avoided, as the medicine is intended to be taken separately from food.


Q: Do any drug interactions for Alfasilin involve blood thinning medicines?

A: Official documentation indicates that the drug's effect on blood clotting measurements is a safety consideration. Ampicillin is associated with a need to monitor prothrombin activity.

This concern is especially relevant when the drug is used concurrently with blood thinning medicines.


Q: Is Alfasilin approved for use in people with liver disease?

A: Alfasilin is officially non-eligible (contraindicated) for patients with a history of hepatic dysfunction or cholestatic jaundice linked to a previous use of the drug.

For patients receiving prolonged therapy, official documents also require periodic monitoring of hepatic (liver) function.


Q: How quickly does Alfasilin leave the body after the last dose?

A: Ampicillin is typically eliminated rapidly from the body. It has a short plasma half-life of approximately 1 to 2 hours, meaning the medicine is generally cleared from the system within 8 to 11 hours after the final dose in individuals with normal kidney function.


Q: Is Alfasilin linked to causing yeast infections?

A: Yes, antibacterial treatments like Alfasilin may allow non-susceptible organisms, such as fungus, to overgrow.

This potential overgrowth is documented in patient information as potentially leading to unwanted infections, such as yeast or fungal infections.


Q: What is Alfasilin specifically approved to treat?

A: Alfasilin (Ampicillin) is approved for the treatment of numerous types of bacterial infections caused by susceptible organisms.

Official indications include infections of the respiratory system, urinary tract, and specific systemic conditions like meningitis and septicemia.


Q: Are generic versions of Alfasilin medically equivalent to the brand name?

A: Official regulatory processes indicate that generic versions of Ampicillin approved by bodies like the FDA must demonstrate bioequivalence to the brand-name product.

This means they contain the same active ingredient and are designed to work the same way in the body as the original medicine.


Q: Can Alfasilin cause confusion or mood changes?

A: Confusion is listed among the possible side effects of Ampicillin, especially when higher doses are administered or in patients who have reduced kidney function.

Changes in a person's mental status are noted as possible central nervous system (CNS) effects that can occur.


Q: How is Alfasilin different from amoxicillin?

A: Both Alfasilin (Ampicillin) and amoxicillin belong to the aminopenicillin class, but official literature notes that they differ in how the body handles them.

Amoxicillin is better absorbed when taken orally. Ampicillin is often used for a wider variety of infections, including specific systemic conditions, and can be administered intravenously.


Q: Is Alfasilin used for skin infections?

A: Ampicillin is an antibacterial drug approved for the treatment of various bacterial infections. Regulatory documents list its use for infections, which includes certain susceptible skin or soft-tissue infections.


Q: What are the common signs of drug resistance when using Alfasilin?

A: When an infection is caused by resistant bacteria, the infection may not be fully resolved with the current medicine or could worsen.

General signs of this lack of effectiveness include the worsening of symptoms or the persistence of symptoms after a few days of treatment.


Q: Can Alfasilin be prescribed for dental infections?

A: Alfasilin is an antibacterial drug approved for treating a wide variety of bacterial infections in the body.

As dental infections are commonly caused by bacteria, Ampicillin may be prescribed for specific types of susceptible dental infections.

How should Alfasilin be stored and disposed of?

Alfasilin (Ampicillin) must be stored and disposed of according to official regulatory requirements to ensure product quality and environmental safety.

Storage Conditions

  • Temperature: Store the dry product (capsules, tablets, or powder) at controlled room temperature, typically below 25 C or 30 C.
  • Protection: The medicine must be protected from moisture and light and kept in its original container, which must be tightly closed.
  • Child Safety: All forms must be stored out of the sight and reach of children.

Stability and Disposal

  • Reconstituted Solution: After the powder for injection is mixed, its stability is limited; it is often required to be used immediately or stored refrigerated (2 C to 8 C) for a short, specific duration.
  • Disposal: Unused or expired medicine must not be disposed of in household waste or wastewater. It must be returned to a pharmacy or designated collection point for proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alfasilin found in:

A-Z Index: